首页 > 最新文献

Bone & Joint Research最新文献

英文 中文
Down-expression of miR-494-3p in senescent osteocyte-derived exosomes inhibits osteogenesis and accelerates age-related bone loss via PTEN/PI3K/AKT pathway. 衰老骨细胞衍生外泌体中 miR-494-3p 的下表达会通过 PTEN/PI3K/AKT 通路抑制成骨过程并加速与年龄相关的骨质流失。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-02-01 DOI: 10.1302/2046-3758.132.bjr-2023-0146.r2
Chen Yao, Jie Sun, Wanxin Luo, Hao Chen, Tianhao Chen, Cao Chen, Bo Zhang, Yafeng Zhang
To investigate the effects of senescent osteocytes on bone homeostasis in the progress of age-related osteoporosis and explore the underlying mechanism.
研究衰老骨细胞在老年性骨质疏松症进展过程中对骨稳态的影响,并探索其潜在机制。
{"title":"Down-expression of miR-494-3p in senescent osteocyte-derived exosomes inhibits osteogenesis and accelerates age-related bone loss via PTEN/PI3K/AKT pathway.","authors":"Chen Yao, Jie Sun, Wanxin Luo, Hao Chen, Tianhao Chen, Cao Chen, Bo Zhang, Yafeng Zhang","doi":"10.1302/2046-3758.132.bjr-2023-0146.r2","DOIUrl":"https://doi.org/10.1302/2046-3758.132.bjr-2023-0146.r2","url":null,"abstract":"To investigate the effects of senescent osteocytes on bone homeostasis in the progress of age-related osteoporosis and explore the underlying mechanism.","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139658746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of EDTA-NS irrigation in eradicating Staphylococcus aureus biofilm-associated infection. EDTA-NS 冲洗在消除金黄色葡萄球菌生物膜相关感染方面的功效。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-01-11 DOI: 10.1302/2046-3758.131.BJR-2023-0141.R1
Junqing Lin, Jinlong Suo, Bingbo Bao, Haifeng Wei, Tao Gao, Hongyi Zhu, Xianyou Zheng

Aims: To investigate the efficacy of ethylenediaminetetraacetic acid-normal saline (EDTA-NS) in dispersing biofilms and reducing bacterial infections.

Methods: EDTA-NS solutions were irrigated at different durations (1, 5, 10, and 30 minutes) and concentrations (1, 2, 5, 10, and 50 mM) to disrupt Staphylococcus aureus biofilms on Matrigel-coated glass and two materials widely used in orthopaedic implants (Ti-6Al-4V and highly cross-linked polyethylene (HXLPE)). To assess the efficacy of biofilm dispersion, crystal violet staining biofilm assay and colony counting after sonification and culturing were performed. The results were further confirmed and visualized by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). We then investigated the efficacies of EDTA-NS irrigation in vivo in rat and pig models of biofilm-associated infection.

Results: When 10 mM or higher EDTA-NS concentrations were used for ten minutes, over 99% of S. aureus biofilm formed on all three types of materials was eradicated in terms of absorbance measured at 595 nm and colony-forming units (CFUs) after culturing. Consistently, SEM and CSLM scanning demonstrated that less adherence of S. aureus could be observed on all three types of materials after 10 mM EDTA-NS irrigation for ten minutes. In the rat model, compared with NS irrigation combined with rifampin (Ti-6Al-4V wire-implanted rats: 60% bacteria survived; HXLPE particle-implanted rats: 63.3% bacteria survived), EDTA-NS irrigation combined with rifampin produced the highest removal rate (Ti-6Al-4V wire-implanted rats: 3.33% bacteria survived; HXLPE particle-implanted rats: 6.67% bacteria survived). In the pig model, compared with NS irrigation combined with rifampin (Ti-6Al-4V plates: 75% bacteria survived; HXLPE bearings: 87.5% bacteria survived), we observed a similar level of biofilm disruption on Ti-6Al-4V plates (25% bacteria survived) and HXLPE bearings (37.5% bacteria survived) after EDTA-NS irrigation combined with rifampin. The in vivo study revealed that the biomass of S. aureus biofilm was significantly reduced when treated with rifampin following irrigation and debridement, as indicated by both the biofilm bacterial burden and crystal violet staining. EDTA-NS irrigation (10 mM/10 min) combined with rifampin effectively removes S. aureus biofilm-associated infections both in vitro and in vivo.

Conclusion: EDTA-NS irrigation with or without antibiotics is effective in eradicating S. aureus biofilm-associated infection both ex and in vivo.

目的:研究乙二胺四乙酸-生理盐水(EDTA-NS)在驱散生物膜和减少细菌感染方面的功效:用不同持续时间(1、5、10 和 30 分钟)和浓度(1、2、5、10 和 50 毫摩尔)的 EDTA-NS 溶液冲洗 Matrigel 涂层玻璃和骨科植入物中广泛使用的两种材料(Ti-6Al-4V 和高交联聚乙烯 (HXLPE))上的金黄色葡萄球菌生物膜。为了评估生物膜分散的效果,在超声和培养后进行了水晶紫染色生物膜检测和菌落计数。共焦激光扫描显微镜(CLSM)和扫描电子显微镜(SEM)对结果进行了进一步的确认和观察。然后,我们在大鼠和猪的生物膜相关感染模型中研究了 EDTA-NS 灌溉的体内疗效:结果:当使用 10 mM 或更高浓度的 EDTA-NS 十分钟后,从 595 纳米吸光度和培养后的菌落形成单位(CFU)来看,在所有三种材料上形成的金黄色葡萄球菌生物膜 99% 以上都被清除了。同样,扫描电子显微镜和 CSLM 扫描显示,在 10 mM EDTA-NS 冲洗十分钟后,金黄色葡萄球菌在三种材料上的附着均有所减少。在大鼠模型中,与结合利福平的 NS 冲洗(Ti-6Al-4V 金属丝植入大鼠:60%的细菌存活;植入 HXLPE 粒子的大鼠:63.3%的细菌存活):63.3%的细菌存活),EDTA-NS冲洗联合利福平的去除率最高(Ti-6Al-4V金属丝植入大鼠:3.33%的细菌存活;HXLPE颗粒植入大鼠:3.33%的细菌存活):植入 Ti-6Al-4V 金属丝的大鼠:3.33% 的细菌存活;植入 HXLPE 粒子的大鼠:6.67% 的细菌存活):细菌存活率为 6.67%)。在猪模型中,与结合利福平的 NS 冲洗相比(Ti-6Al-4V 板:75% 的细菌存活;HXLPE 颗粒:6.67% 的细菌存活),NS 冲洗的细菌存活率更高:细菌存活率为 75%;HXLPE 轴承:细菌存活率为 87.5%)相比,NS 冲洗和利福平联合疗法的效果更好:87.5%的细菌存活)相比,我们观察到在 EDTA-NS 冲洗联合利福平后,Ti-6Al-4V 板(25% 的细菌存活)和 HXLPE 轴承(37.5% 的细菌存活)上的生物膜破坏程度相似。体内研究显示,在灌洗和清创后使用利福平治疗,金黄色葡萄球菌生物膜的生物量明显减少,生物膜细菌负荷和水晶紫染色均表明了这一点。EDTA-NS 冲洗(10 毫摩尔/10 分钟)与利福平联合使用可有效清除金黄色葡萄球菌生物膜相关的体外和体内感染:结论:无论是否使用抗生素,EDTA-NS 冲洗都能有效清除金黄色葡萄球菌生物膜相关感染。
{"title":"Efficacy of EDTA-NS irrigation in eradicating Staphylococcus aureus biofilm-associated infection.","authors":"Junqing Lin, Jinlong Suo, Bingbo Bao, Haifeng Wei, Tao Gao, Hongyi Zhu, Xianyou Zheng","doi":"10.1302/2046-3758.131.BJR-2023-0141.R1","DOIUrl":"10.1302/2046-3758.131.BJR-2023-0141.R1","url":null,"abstract":"<p><strong>Aims: </strong>To investigate the efficacy of ethylenediaminetetraacetic acid-normal saline (EDTA-NS) in dispersing biofilms and reducing bacterial infections.</p><p><strong>Methods: </strong>EDTA-NS solutions were irrigated at different durations (1, 5, 10, and 30 minutes) and concentrations (1, 2, 5, 10, and 50 mM) to disrupt <i>Staphylococcus aureus</i> biofilms on Matrigel-coated glass and two materials widely used in orthopaedic implants (Ti-6Al-4V and highly cross-linked polyethylene (HXLPE)). To assess the efficacy of biofilm dispersion, crystal violet staining biofilm assay and colony counting after sonification and culturing were performed. The results were further confirmed and visualized by confocal laser scanning microscopy (CLSM) and scanning electron microscopy (SEM). We then investigated the efficacies of EDTA-NS irrigation in vivo in rat and pig models of biofilm-associated infection.</p><p><strong>Results: </strong>When 10 mM or higher EDTA-NS concentrations were used for ten minutes, over 99% of <i>S. aureus</i> biofilm formed on all three types of materials was eradicated in terms of absorbance measured at 595 nm and colony-forming units (CFUs) after culturing. Consistently, SEM and CSLM scanning demonstrated that less adherence of <i>S. aureus</i> could be observed on all three types of materials after 10 mM EDTA-NS irrigation for ten minutes. In the rat model, compared with NS irrigation combined with rifampin (Ti-6Al-4V wire-implanted rats: 60% bacteria survived; HXLPE particle-implanted rats: 63.3% bacteria survived), EDTA-NS irrigation combined with rifampin produced the highest removal rate (Ti-6Al-4V wire-implanted rats: 3.33% bacteria survived; HXLPE particle-implanted rats: 6.67% bacteria survived). In the pig model, compared with NS irrigation combined with rifampin (Ti-6Al-4V plates: 75% bacteria survived; HXLPE bearings: 87.5% bacteria survived), we observed a similar level of biofilm disruption on Ti-6Al-4V plates (25% bacteria survived) and HXLPE bearings (37.5% bacteria survived) after EDTA-NS irrigation combined with rifampin. The in vivo study revealed that the biomass of <i>S. aureus</i> biofilm was significantly reduced when treated with rifampin following irrigation and debridement, as indicated by both the biofilm bacterial burden and crystal violet staining. EDTA-NS irrigation (10 mM/10 min) combined with rifampin effectively removes <i>S. aureus</i> biofilm-associated infections both in vitro and in vivo.</p><p><strong>Conclusion: </strong>EDTA-NS irrigation with or without antibiotics is effective in eradicating <i>S. aureus</i> biofilm-associated infection both ex and in vivo.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10781521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139416318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences of NF-κB-targeted therapy for mitigating osteoporosis associated with chronic inflammation of bone. NF-κB 靶向疗法在缓解与骨骼慢性炎症相关的骨质疏松症方面的性别差异。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-01-10 DOI: 10.1302/2046-3758.131.BJR-2023-0040.R3
Masakazu Toya, Junichi Kushioka, Huaishuang Shen, Takeshi Utsunomiya, Hirohito Hirata, Masanori Tsubosaka, Qi Gao, Simon K-H Chow, Ning Zhang, Stuart B Goodman

Aims: Transcription factor nuclear factor kappa B (NF-κB) plays a major role in the pathogenesis of chronic inflammatory diseases in all organ systems. Despite its importance, NF-κB targeted drug therapy to mitigate chronic inflammation has had limited success in preclinical studies. We hypothesized that sex differences affect the response to NF-κB treatment during chronic inflammation in bone. This study investigated the therapeutic effects of NF-κB decoy oligodeoxynucleotides (ODN) during chronic inflammation in male and female mice.

Methods: We used a murine model of chronic inflammation induced by continuous intramedullary delivery of lipopolysaccharide-contaminated polyethylene particles (cPE) using an osmotic pump. Specimens were evaluated using micro-CT and histomorphometric analyses. Sex-specific osteogenic and osteoclastic differentiation potentials were also investigated in vitro, including alkaline phosphatase, Alizarin Red, tartrate-resistant acid phosphatase staining, and gene expression using reverse transcription polymerase chain reaction (RT-PCR).

Results: Local delivery of NF-κB decoy ODN in vivo increased osteogenesis in males, but not females, in the presence of chronic inflammation induced by cPE. Bone resorption activity was decreased in both sexes. In vitro osteogenic and osteoclastic differentiation assays during inflammatory conditions did not reveal differences among the groups. Receptor activator of nuclear factor kappa Β ligand (Rankl) gene expression by osteoblasts was significantly decreased only in males when treated with ODN.

Conclusion: We demonstrated that NF-κB decoy ODN increased osteogenesis in male mice and decreased bone resorption activity in both sexes in preclinical models of chronic inflammation. NF-κB signalling could be a therapeutic target for chronic inflammatory diseases involving bone, especially in males.

目的:转录因子核因子卡巴 B(NF-κB)在所有器官系统的慢性炎症性疾病的发病机制中发挥着重要作用。尽管NF-κB非常重要,但在临床前研究中,NF-κB靶向药物治疗缓解慢性炎症的成功率有限。我们假设,在骨骼慢性炎症期间,性别差异会影响对 NF-κB 治疗的反应。本研究调查了雌雄小鼠慢性炎症期间 NF-κB 诱饵寡脱氧核苷酸(ODN)的治疗效果:我们使用渗透泵连续髓内输送脂多糖污染的聚乙烯颗粒(cPE)诱导小鼠慢性炎症模型。使用显微 CT 和组织形态学分析对标本进行评估。还在体外研究了性别特异性成骨和破骨细胞分化潜能,包括碱性磷酸酶、茜素红、耐酒石酸磷酸酶染色,以及使用反转录聚合酶链反应(RT-PCR)的基因表达:结果:在体内局部给药 NF-κB 诱饵 ODN 能增加男性的骨生成,但不能增加女性的骨生成。两性的骨吸收活性都有所下降。在炎症条件下进行的体外成骨和破骨细胞分化试验并未发现各组之间存在差异。只有男性在接受 ODN 治疗后,成骨细胞的核因子κΒ受体激活剂配体(Rankl)基因表达才会显著下降:我们证明,在慢性炎症的临床前模型中,NF-κB诱饵ODN可增加雄性小鼠的成骨能力,降低雌雄小鼠的骨吸收活性。NF-κB信号可作为涉及骨骼的慢性炎症性疾病的治疗靶点,尤其是在雄性小鼠中。
{"title":"Sex differences of NF-κB-targeted therapy for mitigating osteoporosis associated with chronic inflammation of bone.","authors":"Masakazu Toya, Junichi Kushioka, Huaishuang Shen, Takeshi Utsunomiya, Hirohito Hirata, Masanori Tsubosaka, Qi Gao, Simon K-H Chow, Ning Zhang, Stuart B Goodman","doi":"10.1302/2046-3758.131.BJR-2023-0040.R3","DOIUrl":"10.1302/2046-3758.131.BJR-2023-0040.R3","url":null,"abstract":"<p><strong>Aims: </strong>Transcription factor nuclear factor kappa B (NF-κB) plays a major role in the pathogenesis of chronic inflammatory diseases in all organ systems. Despite its importance, NF-κB targeted drug therapy to mitigate chronic inflammation has had limited success in preclinical studies. We hypothesized that sex differences affect the response to NF-κB treatment during chronic inflammation in bone. This study investigated the therapeutic effects of NF-κB decoy oligodeoxynucleotides (ODN) during chronic inflammation in male and female mice.</p><p><strong>Methods: </strong>We used a murine model of chronic inflammation induced by continuous intramedullary delivery of lipopolysaccharide-contaminated polyethylene particles (cPE) using an osmotic pump. Specimens were evaluated using micro-CT and histomorphometric analyses. Sex-specific osteogenic and osteoclastic differentiation potentials were also investigated in vitro, including alkaline phosphatase, Alizarin Red, tartrate-resistant acid phosphatase staining, and gene expression using reverse transcription polymerase chain reaction (RT-PCR).</p><p><strong>Results: </strong>Local delivery of NF-κB decoy ODN in vivo increased osteogenesis in males, but not females, in the presence of chronic inflammation induced by cPE. Bone resorption activity was decreased in both sexes. In vitro osteogenic and osteoclastic differentiation assays during inflammatory conditions did not reveal differences among the groups. Receptor activator of nuclear factor kappa Β ligand (<i>Rankl)</i> gene expression by osteoblasts was significantly decreased only in males when treated with ODN.</p><p><strong>Conclusion: </strong>We demonstrated that NF-κB decoy ODN increased osteogenesis in male mice and decreased bone resorption activity in both sexes in preclinical models of chronic inflammation. NF-κB signalling could be a therapeutic target for chronic inflammatory diseases involving bone, especially in males.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139401792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The PJI-TNM classification for periprosthetic joint infections. 假体周围关节感染的 PJI-TNM 分类。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-01-05 DOI: 10.1302/2046-3758.131.BJR-2023-0012.R2
Susanne Baertl, Markus Rupp, Maximilian Kerschbaum, Mario Morgenstern, Florian Baumann, Christian Pfeifer, Michael Worlicek, Daniel Popp, Derek F Amanatullah, Volker Alt

Aims: This study aimed to evaluate the clinical application of the PJI-TNM classification for periprosthetic joint infection (PJI) by determining intraobserver and interobserver reliability. To facilitate its use in clinical practice, an educational app was subsequently developed and evaluated.

Methods: A total of ten orthopaedic surgeons classified 20 cases of PJI based on the PJI-TNM classification. Subsequently, the classification was re-evaluated using the PJI-TNM app. Classification accuracy was calculated separately for each subcategory (reinfection, tissue and implant condition, non-human cells, and morbidity of the patient). Fleiss' kappa and Cohen's kappa were calculated for interobserver and intraobserver reliability, respectively.

Results: Overall, interobserver and intraobserver agreements were substantial across the 20 classified cases. Analyses for the variable 'reinfection' revealed an almost perfect interobserver and intraobserver agreement with a classification accuracy of 94.8%. The category 'tissue and implant conditions' showed moderate interobserver and substantial intraobserver reliability, while the classification accuracy was 70.8%. For 'non-human cells,' accuracy was 81.0% and interobserver agreement was moderate with an almost perfect intraobserver reliability. The classification accuracy of the variable 'morbidity of the patient' reached 73.5% with a moderate interobserver agreement, whereas the intraobserver agreement was substantial. The application of the app yielded comparable results across all subgroups.

Conclusion: The PJI-TNM classification system captures the heterogeneity of PJI and can be applied with substantial inter- and intraobserver reliability. The PJI-TNM educational app aims to facilitate application in clinical practice. A major limitation was the correct assessment of the implant situation. To eliminate this, a re-evaluation according to intraoperative findings is strongly recommended.

目的:本研究旨在通过确定观察者内部和观察者之间的可靠性,评估PJI-TNM分类在假体周围关节感染(PJI)中的临床应用。为便于在临床实践中使用,研究人员随后开发并评估了一款教育应用程序:方法:共有 10 名骨科医生根据 PJI-TNM 分类法对 20 例 PJI 病例进行了分类。随后,使用 PJI-TNM 应用程序对分类进行了重新评估。分别计算了每个子类别(再感染、组织和植入物状况、非人类细胞和患者发病率)的分类准确性。弗莱斯卡帕和科恩卡帕分别用于计算观察者间和观察者内的可靠性:总体而言,在 20 个分类病例中,观察者之间和观察者内部的一致性都很高。对变量 "再感染 "的分析表明,观察者间和观察者内的一致性几乎达到了完美的程度,分类准确率为 94.8%。在 "组织和植入物条件 "类别中,观察者间的可靠性和观察者内的可靠性均处于中等水平,分类准确率为 70.8%。非人类细胞 "的准确率为 81.0%,观察者之间的一致性为中等,观察者内部的可靠性几乎为完美。病人发病率 "变量的分类准确率为 73.5%,观察者之间的一致性为中等,而观察者内部的一致性则很高。结论:PJI-TNM 分级系统在所有亚组中的应用结果都具有可比性:结论:PJI-TNM 分类系统捕捉到了 PJI 的异质性,其应用在观察者之间和观察者内部的可靠性都很高。PJI-TNM教育应用程序旨在促进临床实践中的应用。一个主要限制因素是对植入情况的正确评估。为消除这一问题,强烈建议根据术中发现进行重新评估。
{"title":"The PJI-TNM classification for periprosthetic joint infections.","authors":"Susanne Baertl, Markus Rupp, Maximilian Kerschbaum, Mario Morgenstern, Florian Baumann, Christian Pfeifer, Michael Worlicek, Daniel Popp, Derek F Amanatullah, Volker Alt","doi":"10.1302/2046-3758.131.BJR-2023-0012.R2","DOIUrl":"10.1302/2046-3758.131.BJR-2023-0012.R2","url":null,"abstract":"<p><strong>Aims: </strong>This study aimed to evaluate the clinical application of the PJI-TNM classification for periprosthetic joint infection (PJI) by determining intraobserver and interobserver reliability. To facilitate its use in clinical practice, an educational app was subsequently developed and evaluated.</p><p><strong>Methods: </strong>A total of ten orthopaedic surgeons classified 20 cases of PJI based on the PJI-TNM classification. Subsequently, the classification was re-evaluated using the PJI-TNM app. Classification accuracy was calculated separately for each subcategory (reinfection, tissue and implant condition, non-human cells, and morbidity of the patient). Fleiss' kappa and Cohen's kappa were calculated for interobserver and intraobserver reliability, respectively.</p><p><strong>Results: </strong>Overall, interobserver and intraobserver agreements were substantial across the 20 classified cases. Analyses for the variable 'reinfection' revealed an almost perfect interobserver and intraobserver agreement with a classification accuracy of 94.8%. The category 'tissue and implant conditions' showed moderate interobserver and substantial intraobserver reliability, while the classification accuracy was 70.8%. For 'non-human cells,' accuracy was 81.0% and interobserver agreement was moderate with an almost perfect intraobserver reliability. The classification accuracy of the variable 'morbidity of the patient' reached 73.5% with a moderate interobserver agreement, whereas the intraobserver agreement was substantial. The application of the app yielded comparable results across all subgroups.</p><p><strong>Conclusion: </strong>The PJI-TNM classification system captures the heterogeneity of PJI and can be applied with substantial inter- and intraobserver reliability. The PJI-TNM educational app aims to facilitate application in clinical practice. A major limitation was the correct assessment of the implant situation. To eliminate this, a re-evaluation according to intraoperative findings is strongly recommended.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139097262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression. CREB1 抑制剂 666-15 可维持软骨的稳态并缓解骨关节炎的进展。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-01-02 DOI: 10.1302/2046-3758.131.BJR-2023-0016.R2
Ying Wang, Zhimin Wu, Guoqiang Yan, Shan Li, Yanzhuo Zhang, Guangping Li, Chengai Wu

Aims: cAMP response element binding protein (CREB1) is involved in the progression of osteoarthritis (OA). However, available findings about the role of CREB1 in OA are inconsistent. 666-15 is a potent and selective CREB1 inhibitor, but its role in OA is unclear. This study aimed to investigate the precise role of CREB1 in OA, and whether 666-15 exerts an anti-OA effect.

Methods: CREB1 activity and expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) in cells and tissues were measured by immunoblotting and immunohistochemical (IHC) staining. The effect of 666-15 on chondrocyte viability and apoptosis was examined by cell counting kit-8 (CCK-8) assay, JC-10, and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling (TUNEL) staining. The effect of 666-15 on the microstructure of subchondral bone, and the synthesis and catabolism of cartilage, in anterior cruciate ligament transection mice were detected by micro-CT, safranin O and fast green (S/F), immunohistochemical staining, and enzyme-linked immunosorbent assay (ELISA).

Results: CREB1 was hyperactive in osteoarthritic articular cartilage, interleukin (IL)-1β-treated cartilage explants, and IL-1β- or carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-treated chondrocytes. 666-15 enhanced cell viability of OA-like chondrocytes and alleviated IL-1β- or CCCP-induced chondrocyte injury through inhibition of mitochondrial dysfunction-associated apoptosis. Moreover, inhibition of CREB1 by 666-15 suppressed expression of ADAMTS4. Additionally, 666-15 alleviated joint degeneration in an ACLT mouse model.

Conclusion: Hyperactive CREB1 played a critical role in OA development, and 666-15 exerted anti-IL-1β or anti-CCCP effects in vitro as well as joint-protective effects in vivo. 666-15 may therefore be used as a promising anti-OA drug.

目的:cAMP 反应元件结合蛋白(CREB1)与骨关节炎(OA)的进展有关。然而,有关 CREB1 在 OA 中作用的现有研究结果并不一致。666-15 是一种强效的选择性 CREB1 抑制剂,但它在 OA 中的作用尚不清楚。本研究旨在探讨 CREB1 在 OA 中的确切作用,以及 666-15 是否具有抗 OA 作用:方法:通过免疫印迹和免疫组织化学(IHC)染色检测细胞和组织中 CREB1 的活性和具有血栓软骨素基序 4 的崩解素和金属蛋白酶(ADAMTS4)的表达。细胞计数试剂盒-8(CCK-8)测定法、JC-10 和末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)染色法检测了 666-15 对软骨细胞活力和凋亡的影响。通过显微 CT、黄蓍素 O 和快绿素(S/F)、免疫组化染色和酶联免疫吸附试验(ELISA)检测了 666-15 对前十字韧带横断小鼠软骨下骨的微观结构以及软骨的合成和分解的影响:结果:CREB1在骨关节炎关节软骨、白细胞介素(IL)-1β处理过的软骨外植体、IL-1β或羰基氰化3-氯苯腙(CCCP)处理过的软骨细胞中活性亢进。666-15 通过抑制线粒体功能障碍相关的细胞凋亡,增强了 OA 类软骨细胞的细胞活力,减轻了 IL-1β 或 CCCP 诱导的软骨细胞损伤。此外,666-15 对 CREB1 的抑制还能抑制 ADAMTS4 的表达。此外,666-15 还能缓解 ACLT 小鼠模型中的关节退化:结论:亢进的 CREB1 在 OA 发生过程中起着关键作用,666-15 在体外具有抗 IL-1β 或抗CCCP 的作用,在体内具有保护关节的作用。因此,666-15 可以作为一种很有前景的抗 OA 药物。
{"title":"The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.","authors":"Ying Wang, Zhimin Wu, Guoqiang Yan, Shan Li, Yanzhuo Zhang, Guangping Li, Chengai Wu","doi":"10.1302/2046-3758.131.BJR-2023-0016.R2","DOIUrl":"10.1302/2046-3758.131.BJR-2023-0016.R2","url":null,"abstract":"<p><strong>Aims: </strong>cAMP response element binding protein (CREB1) is involved in the progression of osteoarthritis (OA). However, available findings about the role of CREB1 in OA are inconsistent. 666-15 is a potent and selective CREB1 inhibitor, but its role in OA is unclear. This study aimed to investigate the precise role of CREB1 in OA, and whether 666-15 exerts an anti-OA effect.</p><p><strong>Methods: </strong>CREB1 activity and expression of a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) in cells and tissues were measured by immunoblotting and immunohistochemical (IHC) staining. The effect of 666-15 on chondrocyte viability and apoptosis was examined by cell counting kit-8 (CCK-8) assay, JC-10, and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labelling (TUNEL) staining. The effect of 666-15 on the microstructure of subchondral bone, and the synthesis and catabolism of cartilage, in anterior cruciate ligament transection mice were detected by micro-CT, safranin O and fast green (S/F), immunohistochemical staining, and enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>CREB1 was hyperactive in osteoarthritic articular cartilage, interleukin (IL)-1β-treated cartilage explants, and IL-1β- or carbonyl cyanide 3-chlorophenylhydrazone (CCCP)-treated chondrocytes. 666-15 enhanced cell viability of OA-like chondrocytes and alleviated IL-1β- or CCCP-induced chondrocyte injury through inhibition of mitochondrial dysfunction-associated apoptosis. Moreover, inhibition of CREB1 by 666-15 suppressed expression of ADAMTS4. Additionally, 666-15 alleviated joint degeneration in an ACLT mouse model.</p><p><strong>Conclusion: </strong>Hyperactive CREB1 played a critical role in OA development, and 666-15 exerted anti-IL-1β or anti-CCCP effects in vitro as well as joint-protective effects in vivo. 666-15 may therefore be used as a promising anti-OA drug.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10758301/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewer acknowledgement. 审稿人致谢。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2024-01-01 DOI: 10.1302/2046-3758.131.BJR-2024-00001
A Hamish R W Simpson
{"title":"Reviewer acknowledgement.","authors":"A Hamish R W Simpson","doi":"10.1302/2046-3758.131.BJR-2024-00001","DOIUrl":"10.1302/2046-3758.131.BJR-2024-00001","url":null,"abstract":"","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139073341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomimetic vascularized adipose-derived mesenchymal stem cells bone-periosteum graft enhances angiogenesis and osteogenesis in a male rabbit spine fusion model. 仿生血管化脂肪间充质干细胞骨-骨膜移植可增强雄性兔脊柱融合模型的血管生成和骨生成。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2023-12-06 DOI: 10.1302/2046-3758.1212.BJR-2023-0013.R1
Tsai-Sheng Fu, Wei-Chuan Chen, Ying-Chih Wang, Chia-Wei Chang, Tung-Yi Lin, Chak-Bor Wong

Aims: Several artificial bone grafts have been developed but fail to achieve anticipated osteogenesis due to their insufficient neovascularization capacity and periosteum support. This study aimed to develop a vascularized bone-periosteum construct (VBPC) to provide better angiogenesis and osteogenesis for bone regeneration.

Methods: A total of 24 male New Zealand white rabbits were divided into four groups according to the experimental materials. Allogenic adipose-derived mesenchymal stem cells (AMSCs) were cultured and seeded evenly in the collagen/chitosan sheet to form cell sheet as periosteum. Simultaneously, allogenic AMSCs were seeded onto alginate beads and were cultured to differentiate to endothelial-like cells to form vascularized bone construct (VBC). The cell sheet was wrapped onto VBC to create a vascularized bone-periosteum construct (VBPC). Four different experimental materials - acellular construct, VBC, non-vascularized bone-periosteum construct, and VBPC - were then implanted in bilateral L4-L5 intertransverse space. At 12 weeks post-surgery, the bone-forming capacities were determined by CT, biomechanical testing, histology, and immunohistochemistry staining analyses.

Results: At 12 weeks, the VBPC group significantly increased new bone formation volume compared with the other groups. Biomechanical testing demonstrated higher torque strength in the VBPC group. Notably, the haematoxylin and eosin, Masson's trichrome, and immunohistochemistry-stained histological results revealed that VBPC promoted neovascularization and new bone formation in the spine fusion areas.

Conclusion: The tissue-engineered VBPC showed great capability in promoting angiogenesis and osteogenesis in vivo. It may provide a novel approach to create a superior blood supply and nutritional environment to overcome the deficits of current artificial bone graft substitutes.

目的:目前已开发出多种人工骨移植物,但由于其血管新生能力和骨膜支持不足,无法实现预期的成骨效果。本研究旨在开发一种血管化骨骨膜构建体(VBPC),为骨再生提供更好的血管生成和成骨能力:方法:将 24 只雄性新西兰白兔按实验材料分为四组。方法:将 24 只雄性新西兰白兔按实验材料分为四组,分别培养异基因脂肪间充质干细胞(AMSCs)并将其均匀播种在胶原蛋白/壳聚糖薄片上,形成细胞薄片作为骨膜。同时,将异源 AMSCs 接种到藻酸盐珠上,培养分化为内皮样细胞,形成血管化骨构建物(VBC)。将细胞薄片包裹在 VBC 上,形成血管化骨-骨膜构建体(VBPC)。然后将四种不同的实验材料--无细胞构建物、VBC、无血管化骨-骨膜构建物和 VBPC--植入双侧 L4-L5 横向间隙。术后 12 周,通过 CT、生物力学测试、组织学和免疫组化染色分析确定骨形成能力:结果:12 周时,VBPC 组与其他组相比,新骨形成量明显增加。生物力学测试表明,VBPC 组的扭矩强度更高。值得注意的是,血红素和伊红、Masson 三色和免疫组化染色的组织学结果显示,VBPC 促进了脊柱融合区域的新生血管形成和新骨形成:结论:组织工程 VBPC 在促进体内血管生成和骨生成方面表现出了强大的能力。结论:组织工程 VBPC 在促进体内血管生成和骨生成方面表现出很强的能力,可为创造良好的血液供应和营养环境提供一种新方法,以克服当前人工骨移植替代物的不足。
{"title":"Biomimetic vascularized adipose-derived mesenchymal stem cells bone-periosteum graft enhances angiogenesis and osteogenesis in a male rabbit spine fusion model.","authors":"Tsai-Sheng Fu, Wei-Chuan Chen, Ying-Chih Wang, Chia-Wei Chang, Tung-Yi Lin, Chak-Bor Wong","doi":"10.1302/2046-3758.1212.BJR-2023-0013.R1","DOIUrl":"10.1302/2046-3758.1212.BJR-2023-0013.R1","url":null,"abstract":"<p><strong>Aims: </strong>Several artificial bone grafts have been developed but fail to achieve anticipated osteogenesis due to their insufficient neovascularization capacity and periosteum support. This study aimed to develop a vascularized bone-periosteum construct (VBPC) to provide better angiogenesis and osteogenesis for bone regeneration.</p><p><strong>Methods: </strong>A total of 24 male New Zealand white rabbits were divided into four groups according to the experimental materials. Allogenic adipose-derived mesenchymal stem cells (AMSCs) were cultured and seeded evenly in the collagen/chitosan sheet to form cell sheet as periosteum. Simultaneously, allogenic AMSCs were seeded onto alginate beads and were cultured to differentiate to endothelial-like cells to form vascularized bone construct (VBC). The cell sheet was wrapped onto VBC to create a vascularized bone-periosteum construct (VBPC). Four different experimental materials - acellular construct, VBC, non-vascularized bone-periosteum construct, and VBPC - were then implanted in bilateral L4-L5 intertransverse space. At 12 weeks post-surgery, the bone-forming capacities were determined by CT, biomechanical testing, histology, and immunohistochemistry staining analyses.</p><p><strong>Results: </strong>At 12 weeks, the VBPC group significantly increased new bone formation volume compared with the other groups. Biomechanical testing demonstrated higher torque strength in the VBPC group. Notably, the haematoxylin and eosin, Masson's trichrome, and immunohistochemistry-stained histological results revealed that VBPC promoted neovascularization and new bone formation in the spine fusion areas.</p><p><strong>Conclusion: </strong>The tissue-engineered VBPC showed great capability in promoting angiogenesis and osteogenesis in vivo. It may provide a novel approach to create a superior blood supply and nutritional environment to overcome the deficits of current artificial bone graft substitutes.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2023-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697772/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138486658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hip joint contact pressure and force: a scoping review of in vivo and cadaver studies. 髋关节接触压力和力:体内和尸体研究的范围综述。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2023-12-04 DOI: 10.1302/2046-3758.1212.BJR-2022-0461.R2
Pedro Dantas, Sergio R Gonçalves, André Grenho, Vasco Mascarenhas, Jorge Martins, Miguel Tavares da Silva, Sergio B Gonçalves, José Guimarães Consciência

Aims: Research on hip biomechanics has analyzed femoroacetabular contact pressures and forces in distinct hip conditions, with different procedures, and used diverse loading and testing conditions. The aim of this scoping review was to identify and summarize the available evidence in the literature for hip contact pressures and force in cadaver and in vivo studies, and how joint loading, labral status, and femoral and acetabular morphology can affect these biomechanical parameters.

Methods: We used the PRISMA extension for scoping reviews for this literature search in three databases. After screening, 16 studies were included for the final analysis.

Results: The studies assessed different hip conditions like labrum status, the biomechanical effect of the cam, femoral version, acetabular coverage, and the effect of rim trimming. The testing and loading conditions were also quite diverse, and this disparity limits direct comparisons between the different researches. With normal anatomy the mean contact pressures ranged from 1.54 to 4.4 MPa, and the average peak contact pressures ranged from 2 to 9.3 MPa. Labral tear or resection showed an increase in contact pressures that diminished after repair or reconstruction of the labrum. Complete cam resection also decreased the contact pressure, and acetabular rim resection of 6 mm increased the contact pressure at the acetabular base.

Conclusion: To date there is no standardized methodology to access hip contact biomechanics in hip arthroscopy, or with the preservation of the periarticular soft-tissues. A tendency towards improved biomechanics (lower contact pressures) was seen with labral repair and reconstruction techniques as well as with cam correction.

目的:髋关节生物力学研究分析了不同髋关节状态、不同手术方式、不同加载和测试条件下股骨髋臼接触压力和力。本综述的目的是识别和总结文献中关于尸体和体内研究中髋关节接触压力和力的现有证据,以及关节负荷、唇部状态、股骨和髋臼形态如何影响这些生物力学参数。方法:我们使用PRISMA扩展对三个数据库的文献检索进行范围综述。筛选后,纳入16项研究进行最终分析。结果:研究评估了不同的髋关节状况,如唇形状态、凸轮的生物力学效应、股骨版本、髋臼覆盖率和边缘修剪的效果。试验和加载条件也存在较大差异,这种差异限制了不同研究之间的直接比较。正常解剖时,平均接触压力为1.54 ~ 4.4 MPa,平均峰值接触压力为2 ~ 9.3 MPa。唇部撕裂或切除显示接触压力增加,在唇部修复或重建后减少。完全凸轮切除也降低了接触压力,髋臼边缘切除6mm增加了髋臼底部的接触压力。结论:迄今为止,还没有标准化的方法来获取髋关节镜下髋关节接触生物力学,或保留关节周围软组织。通过唇部修复和重建技术以及凸轮矫正,可以看到改善生物力学(降低接触压力)的趋势。
{"title":"Hip joint contact pressure and force: a scoping review of in vivo and cadaver studies.","authors":"Pedro Dantas, Sergio R Gonçalves, André Grenho, Vasco Mascarenhas, Jorge Martins, Miguel Tavares da Silva, Sergio B Gonçalves, José Guimarães Consciência","doi":"10.1302/2046-3758.1212.BJR-2022-0461.R2","DOIUrl":"10.1302/2046-3758.1212.BJR-2022-0461.R2","url":null,"abstract":"<p><strong>Aims: </strong>Research on hip biomechanics has analyzed femoroacetabular contact pressures and forces in distinct hip conditions, with different procedures, and used diverse loading and testing conditions. The aim of this scoping review was to identify and summarize the available evidence in the literature for hip contact pressures and force in cadaver and in vivo studies, and how joint loading, labral status, and femoral and acetabular morphology can affect these biomechanical parameters.</p><p><strong>Methods: </strong>We used the PRISMA extension for scoping reviews for this literature search in three databases. After screening, 16 studies were included for the final analysis.</p><p><strong>Results: </strong>The studies assessed different hip conditions like labrum status, the biomechanical effect of the cam, femoral version, acetabular coverage, and the effect of rim trimming. The testing and loading conditions were also quite diverse, and this disparity limits direct comparisons between the different researches. With normal anatomy the mean contact pressures ranged from 1.54 to 4.4 MPa, and the average peak contact pressures ranged from 2 to 9.3 MPa. Labral tear or resection showed an increase in contact pressures that diminished after repair or reconstruction of the labrum. Complete cam resection also decreased the contact pressure, and acetabular rim resection of 6 mm increased the contact pressure at the acetabular base.</p><p><strong>Conclusion: </strong>To date there is no standardized methodology to access hip contact biomechanics in hip arthroscopy, or with the preservation of the periarticular soft-tissues. A tendency towards improved biomechanics (lower contact pressures) was seen with labral repair and reconstruction techniques as well as with cam correction.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693937/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138476777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Classification of distinct osteoarthritis subtypes with different knee joint tissues by gene expression profiles. 不同膝关节组织的不同骨关节炎亚型的基因表达谱分类。
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2023-12-01 DOI: 10.1302/2046-3758.1212.BJR-2023-0021.R2
Yuan Xue, Liang Zhou, Jiaqian Wang

Aims: Knee osteoarthritis (OA) involves a variety of tissues in the joint. Gene expression profiles in different tissues are of great importance in order to understand OA.

Methods: First, we obtained gene expression profiles of cartilage, synovium, subchondral bone, and meniscus from the Gene Expression Omnibus (GEO). Several datasets were standardized by merging and removing batch effects. Then, we used unsupervised clustering to divide OA into three subtypes. The gene ontology and pathway enrichment of three subtypes were analyzed. CIBERSORT was used to evaluate the infiltration of immune cells in different subtypes. Finally, OA-related genes were obtained from the Molecular Signatures Database for validation, and diagnostic markers were screened according to clinical characteristics. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to verify the effectiveness of markers.

Results: C1 subtype is mainly concentrated in the development of skeletal muscle organs, C2 lies in metabolic process and immune response, and C3 in pyroptosis and cell death process. Therefore, we divided OA into three subtypes: bone remodelling subtype (C1), immune metabolism subtype (C2), and cartilage degradation subtype (C3). The number of macrophage M0 and activated mast cells of C2 subtype was significantly higher than those of the other two subtypes. COL2A1 has significant differences in different subtypes. The expression of COL2A1 is related to age, and trafficking protein particle complex subunit 2 is related to the sex of OA patients.

Conclusion: This study linked different tissues with gene expression profiles, revealing different molecular subtypes of patients with knee OA. The relationship between clinical characteristics and OA-related genes was also studied, which provides a new concept for the diagnosis and treatment of OA.

目的:膝关节骨性关节炎(OA)涉及关节的多种组织。不同组织中的基因表达谱对了解OA具有重要意义。方法:首先,我们从gene expression Omnibus (GEO)获得软骨、滑膜、软骨下骨和半月板的基因表达谱。几个数据集通过合并和去除批处理效果来标准化。然后,我们使用无监督聚类将OA划分为三个亚型。分析了三种亚型的基因本体和途径富集情况。采用CIBERSORT法评价不同亚型免疫细胞的浸润情况。最后从分子特征数据库中获取oa相关基因进行验证,并根据临床特征筛选诊断标记物。采用定量反转录聚合酶链反应(qRT-PCR)验证标记的有效性。结果:C1亚型主要集中在骨骼肌器官的发育过程中,C2亚型参与代谢过程和免疫反应,C3亚型参与焦亡和细胞死亡过程。因此,我们将OA分为三个亚型:骨重塑亚型(C1)、免疫代谢亚型(C2)和软骨降解亚型(C3)。C2亚型巨噬细胞M0和活化肥大细胞数量明显高于其他两种亚型。COL2A1在不同亚型中存在显著差异。COL2A1的表达与年龄有关,转运蛋白颗粒复合物亚基2的表达与OA患者的性别有关。结论:本研究将不同组织与基因表达谱联系起来,揭示了膝关节OA患者不同的分子亚型。研究了临床特征与OA相关基因的关系,为OA的诊断和治疗提供了新的思路。
{"title":"Classification of distinct osteoarthritis subtypes with different knee joint tissues by gene expression profiles.","authors":"Yuan Xue, Liang Zhou, Jiaqian Wang","doi":"10.1302/2046-3758.1212.BJR-2023-0021.R2","DOIUrl":"10.1302/2046-3758.1212.BJR-2023-0021.R2","url":null,"abstract":"<p><strong>Aims: </strong>Knee osteoarthritis (OA) involves a variety of tissues in the joint. Gene expression profiles in different tissues are of great importance in order to understand OA.</p><p><strong>Methods: </strong>First, we obtained gene expression profiles of cartilage, synovium, subchondral bone, and meniscus from the Gene Expression Omnibus (GEO). Several datasets were standardized by merging and removing batch effects. Then, we used unsupervised clustering to divide OA into three subtypes. The gene ontology and pathway enrichment of three subtypes were analyzed. CIBERSORT was used to evaluate the infiltration of immune cells in different subtypes. Finally, OA-related genes were obtained from the Molecular Signatures Database for validation, and diagnostic markers were screened according to clinical characteristics. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to verify the effectiveness of markers.</p><p><strong>Results: </strong>C1 subtype is mainly concentrated in the development of skeletal muscle organs, C2 lies in metabolic process and immune response, and C3 in pyroptosis and cell death process. Therefore, we divided OA into three subtypes: bone remodelling subtype (C1), immune metabolism subtype (C2), and cartilage degradation subtype (C3). The number of macrophage M0 and activated mast cells of C2 subtype was significantly higher than those of the other two subtypes. COL2A1 has significant differences in different subtypes. The expression of COL2A1 is related to age, and trafficking protein particle complex subunit 2 is related to the sex of OA patients.</p><p><strong>Conclusion: </strong>This study linked different tissues with gene expression profiles, revealing different molecular subtypes of patients with knee OA. The relationship between clinical characteristics and OA-related genes was also studied, which provides a new concept for the diagnosis and treatment of OA.</p>","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138457749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development EDIL3 在维持软骨细胞外基质和抑制骨关节炎发展中的作用
IF 4.6 2区 医学 Q1 Medicine Pub Date : 2023-12-01 DOI: 10.1302/2046-3758.1212.BJR-2023-0087.R1
Mei-Feng Chen, Chih-Chien Hu, Yung-Heng Hsu, Yu-Chih Lin, Kai-Lin Chen, Steve W. N. Ueng, Yuhan Chang
Aims Therapeutic agents that prevent chondrocyte loss, extracellular matrix (ECM) degradation, and osteoarthritis (OA) progression are required. The expression level of epidermal growth factor (EGF)-like repeats and discoidin I-like domains-containing protein 3 (EDIL3) in damaged human cartilage is significantly higher than in undamaged cartilage. However, the effect of EDIL3 on cartilage is still unknown. Methods We used human cartilage plugs (ex vivo) and mice with spontaneous OA (in vivo) to explore whether EDIL3 has a chondroprotective effect by altering OA-related indicators. Results EDIL3 protein prevented chondrocyte clustering and maintained chondrocyte number and SOX9 expression in the human cartilage plug. Administration of EDIL3 protein prevented OA progression in STR/ort mice by maintaining the number of chondrocytes in the hyaline cartilage and the number of matrix-producing chondrocytes (MPCs). It reduced the degradation of aggrecan, the expression of matrix metalloproteinase (MMP)-13, the Osteoarthritis Research Society International (OARSI) score, and bone remodelling. It increased the porosity of the subchondral bone plate. Administration of an EDIL3 antibody increased the number of matrix-non-producing chondrocytes (MNCs) in cartilage and exacerbated the serum concentrations of OA-related pro-inflammatory cytokines, including monocyte chemotactic protein-3 (MCP-3), RANTES, interleukin (IL)-17A, IL-22, and GROα. Administration of β1 and β3 integrin agonists (CD98 protein) increased the expression of SOX9 in OA mice. Hence, EDIL3 might activate β1 and β3 integrins for chondroprotection. EDIL3 may also protect cartilage by attenuating the expression of IL-1β-enhanced phosphokinase proteins in chondrocytes, especially glycogen synthase kinase 3 alpha/beta (GSK-3α/β) and phospholipase C gamma 1 (PLC-γ1). Conclusion EDIL3 has a role in maintaining the cartilage ECM and inhibiting the development of OA, making it a potential therapeutic drug for OA. Cite this article: Bone Joint Res 2023;12(12):734–746.
目的:需要预防软骨细胞丢失、细胞外基质(ECM)降解和骨关节炎(OA)进展的治疗药物。损伤软骨中表皮生长因子(EGF)样重复序列和盘状蛋白i样结构域蛋白3 (EDIL3)的表达水平显著高于未损伤软骨。然而,EDIL3对软骨的影响尚不清楚。方法采用人软骨塞(离体)和自发性OA小鼠(体内),探讨EDIL3是否通过改变OA相关指标具有软骨保护作用。结果EDIL3蛋白抑制软骨细胞聚集,维持软骨细胞数量和SOX9表达。EDIL3蛋白通过维持透明软骨中的软骨细胞数量和基质生成软骨细胞(MPCs)的数量来阻止STR/ort小鼠OA的进展。它降低了聚集蛋白的降解、基质金属蛋白酶(MMP)-13的表达、国际骨关节炎研究学会(OARSI)评分和骨重塑。它增加了软骨下骨板的孔隙度。EDIL3抗体增加了软骨中不产生基质的软骨细胞(mnc)的数量,并增加了oa相关的促炎细胞因子的血清浓度,包括单核细胞趋化蛋白-3 (MCP-3)、RANTES、白细胞介素(IL)-17A、IL-22和GROα。给予β1和β3整合素激动剂(CD98蛋白)可增加OA小鼠SOX9的表达。因此,EDIL3可能激活β1和β3整合素来保护软骨。EDIL3还可能通过减弱软骨细胞中il -1β增强的磷酸激酶蛋白的表达,特别是糖原合成酶激酶3α/β (GSK-3α/β)和磷脂酶C γ1 (PLC-γ1)的表达来保护软骨。结论EDIL3具有维持软骨ECM、抑制骨性关节炎发展的作用,是治疗骨性关节炎的潜在药物。本文引自:骨关节,2023;12(12):734-746。
{"title":"The role of EDIL3 in maintaining cartilage extracellular matrix and inhibiting osteoarthritis development","authors":"Mei-Feng Chen, Chih-Chien Hu, Yung-Heng Hsu, Yu-Chih Lin, Kai-Lin Chen, Steve W. N. Ueng, Yuhan Chang","doi":"10.1302/2046-3758.1212.BJR-2023-0087.R1","DOIUrl":"https://doi.org/10.1302/2046-3758.1212.BJR-2023-0087.R1","url":null,"abstract":"Aims Therapeutic agents that prevent chondrocyte loss, extracellular matrix (ECM) degradation, and osteoarthritis (OA) progression are required. The expression level of epidermal growth factor (EGF)-like repeats and discoidin I-like domains-containing protein 3 (EDIL3) in damaged human cartilage is significantly higher than in undamaged cartilage. However, the effect of EDIL3 on cartilage is still unknown. Methods We used human cartilage plugs (ex vivo) and mice with spontaneous OA (in vivo) to explore whether EDIL3 has a chondroprotective effect by altering OA-related indicators. Results EDIL3 protein prevented chondrocyte clustering and maintained chondrocyte number and SOX9 expression in the human cartilage plug. Administration of EDIL3 protein prevented OA progression in STR/ort mice by maintaining the number of chondrocytes in the hyaline cartilage and the number of matrix-producing chondrocytes (MPCs). It reduced the degradation of aggrecan, the expression of matrix metalloproteinase (MMP)-13, the Osteoarthritis Research Society International (OARSI) score, and bone remodelling. It increased the porosity of the subchondral bone plate. Administration of an EDIL3 antibody increased the number of matrix-non-producing chondrocytes (MNCs) in cartilage and exacerbated the serum concentrations of OA-related pro-inflammatory cytokines, including monocyte chemotactic protein-3 (MCP-3), RANTES, interleukin (IL)-17A, IL-22, and GROα. Administration of β1 and β3 integrin agonists (CD98 protein) increased the expression of SOX9 in OA mice. Hence, EDIL3 might activate β1 and β3 integrins for chondroprotection. EDIL3 may also protect cartilage by attenuating the expression of IL-1β-enhanced phosphokinase proteins in chondrocytes, especially glycogen synthase kinase 3 alpha/beta (GSK-3α/β) and phospholipase C gamma 1 (PLC-γ1). Conclusion EDIL3 has a role in maintaining the cartilage ECM and inhibiting the development of OA, making it a potential therapeutic drug for OA. Cite this article: Bone Joint Res 2023;12(12):734–746.","PeriodicalId":9074,"journal":{"name":"Bone & Joint Research","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138622079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bone & Joint Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1